Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care | MicrobiomeTrials← Back to trialsNCT07246265
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-03-05Est. Completion: 2028-09
Enrollment target: 100 participants Locations- CHRU de Tours, Tours, France, France
- Henri-Mondor, Créteil, France
- CH Le Mans, Le Mans, France
- CHU de Nantes, Nantes, France
- CHU d'Orléans, Orléans, France
- CHU de Rennes, Rennes, France
Other microbiome trials you might be interested in
Sickle Cell Disease, Hemolytic Anemia
Background:
Sickle cell disease (SCD) is an inherited blood disorder. The disease affects the ability of red blood cell…
Bethesda, United StatesEst. completion Apr 27, 2027
Sickle Cell DiseasePulmonary DiseaseRenal DiseaseHeart Disease
Sickle Cell Disease is one of the most common genetic diseases in the United States, occurring in approximately 1 in 400…
Washington D.C., United StatesEst. completion Nov 2026
This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibro…
Los Angeles, United StatesEst. completion Dec 2026